Urolithiasis - Pathology, Medicine, Surgery

Reading File
Finding Sources
Searching PubMed

"urolithiasis"[MeSH Terms] AND "management"[MeSH Terms]

Reading File
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Reading File

Urolithiasis - Comprehensive Review

1. PATHOLOGY

Definition

Urolithiasis refers to calculus formation at any level of the urinary collecting system; most calculi arise in the kidney (nephrolithiasis). It is the common final manifestation of a variety of underlying pathophysiologic processes - not a single diagnosis per se - and although the stones are localized to the urinary tract, it is fundamentally a systemic disorder. - Brenner & Rector's The Kidney, p. 1277

Epidemiology

  • Lifetime prevalence: 1-20%; rising steadily over four decades in Western populations
  • By age 70: ~11% of men and 5.6% of women in the US will develop a symptomatic kidney stone
  • Recurrence is high: ~50% within the first decade
  • Men are 2x more likely to form stones; peak incidence in the 4th-6th decades; women have a bimodal peak (3rd decade and postmenopause)
  • White individuals have higher risk; family history confers 2.5x risk
  • Estimated economic burden in the United States approaching $4.7 billion by 2030
  • Robbins & Kumar Basic Pathology, p. 527; Bailey & Love's Surgery 28th ed., p. 1496; Brenner & Rector's The Kidney, p. 1277

Pathogenesis

Stone formation follows a cascade:
  1. Supersaturation - When urinary concentrations of lithogenic solutes exceed their solubility product, crystallization begins
  2. Inhibitor failure - Normal urine contains crystal-growth inhibitors: citrate, potassium, magnesium, Tamm-Horsfall mucoprotein. When these are depleted or overwhelmed, nucleation proceeds
  3. Crystal nucleation and anchoring - Crystals either pass with urine or anchor onto renal papillae as Randall's plaques (subepithelial calcium phosphate deposits), which serve as a fixed nidus
  4. pH effects - Acidic urine (pH <5.5) favors uric acid and cystine precipitation; alkaline urine favors calcium phosphate and struvite formation
  5. Urinary stasis - Promotes crystal aggregation; stasis stones are typically multiple, round, smooth ("milk of calcium stones")
  6. Organic matrix - All stone types contain ~2.5% mucoprotein matrix by weight
  • Bailey & Love's Surgery 28th ed., p. 1496; Robbins & Kumar Basic Pathology, p. 527

Stone Types

Nephrolithiasis: small golden calculi impacted in the renal pelvis
Gross pathology: small calculi impacted in the renal pelvis (Robbins & Kumar Basic Pathology)
Stone TypePrevalenceUrine pHRadiologyKey Cause
Calcium oxalate ± phosphate~80%Any (CaOx); Alkaline (CaPO4)RadiopaqueHypercalciuria, hyperoxaluria, hypocitraturia
Struvite (Mg-NH3-PO4)~10%AlkalineRadiopaque (staghorn)UTI - urease producers (Proteus, Klebsiella)
Uric acid6-9%Acidic <5.5Radiolucent (X-ray); visible on CTGout, myeloproliferative disorders, persistently acidic urine
Cystine1-2%AcidicFaintly opaqueAutosomal recessive cystinuria
  • Robbins & Kumar Basic Pathology, Table 12.5, p. 527-528

Calcium Stones - Causes

  • Idiopathic hypercalciuria (50% of calcium stone formers): subdivided into absorptive (excessive gut calcium absorption) and renal (tubular reabsorption defect)
  • Primary hyperparathyroidism: most common hypercalcemic cause; PTH drives bone resorption and 1,25-dihydroxyvitamin D3 synthesis, increasing intestinal calcium absorption
  • Hyperoxaluria: enteric (ileal disease/resection increases colonic oxalate absorption) or primary (rare enzymatic defect)
  • Hypocitraturia: distal RTA is the classic cause; citrate normally chelates urinary calcium
  • Hyperuricosuria: uric acid crystals act as heterogeneous nidi for calcium oxalate crystallization
  • No identified metabolic abnormality in 15-20% of calcium stone formers

Struvite Stones

  • Form only in the presence of urease-producing bacteria: Proteus, Klebsiella, Serratia, Enterobacter
  • Urease hydrolyzes urea to CO2 and ammonium, raising urine pH and precipitating magnesium-ammonium-phosphate
  • Staghorn calculi - branch through the entire pelvicalyceal system; cause progressive renal destruction through chronic infection and obstructive uropathy; complete clearance is mandatory since residual fragments cause rapid recurrence and persistent bacteriuria

Uric Acid Stones

  • Radiolucent on plain radiograph (but visible on CT - important diagnostic point)
  • 50% of uric acid stone formers have neither hyperuricemia nor increased urinary urate; they simply excrete persistently acidic urine (pH <5.5) - unexplained
  • Conditions causing hyperuricosuria: gout, myeloproliferative disorders post-cytotoxic therapy
  • Highest geographic prevalence in the Middle East

Cystine Stones

  • Autosomal recessive defect in renal proximal tubular and intestinal transport of cystine, ornithine, lysine, arginine (COLA)
  • Cystine insoluble even at physiologic pH; worsens with acidic urine
  • Very hard due to disulfide bonds - essentially resistant to ESWL

Morphology

  • Unilateral in ~80% of patients
  • Most common sites: renal pelvis, calyces, bladder
  • Typically 2-3 mm; may be smooth or jagged
  • Staghorn calculi: massive branching structures creating a cast of the pelvicalyceal system - almost always struvite
  • Stones cause mucosal ulceration, hemorrhage, and obstruction; the latter leads to hydronephrosis and, if chronic, loss of renal function
  • Robbins & Kumar Basic Pathology, p. 528

2. MEDICINE

Clinical Presentation

  • Asymptomatic: increasingly diagnosed incidentally on imaging, especially large pelvic stones
  • Ureteric colic: sudden-onset excruciating flank pain radiating to groin, scrotum/labia; caused by hyperperistalsis of ureteric musculature against an obstructing stone
    • Small (3-5 mm) calculi most commonly lodge at the ureterovesical junction (UVJ)
    • Lower ureteric/UVJ stones cause additional urgency, frequency, dysuria
  • Hematuria: gross or microscopic in most cases
  • Calculuria: passage of sand or gravel
  • Nausea and vomiting: from shared celiac innervation
  • Fever and rigors: indicates concurrent UTI/urosepsis - a urological emergency
  • Malaise and weight loss: with longstanding infection stones or renal failure

Differential Diagnosis of Ureteric Colic

  • Clot colic (anticoagulation, haemophilia), papillary necrosis
  • Acute appendicitis, bowel obstruction, abdominal aortic aneurysm
  • Ectopic pregnancy, ovarian torsion
  • Malingering

Investigations

Emergency:
  • Urinalysis: hematuria, pyuria (sterile or infected), pH
  • Urine culture: if infection suspected or intervention planned
  • Bloods: FBC, serum creatinine, electrolytes, calcium, uric acid; pregnancy test (women)
  • Plain KUB: detects radiopaque stones; misses uric acid and most cystine stones
  • Ultrasound: first-line in children, pregnant women; detects hydronephrosis and stones at kidney/UVJ
  • Non-contrast CT (NCCT): gold standard - detects all stone types except indinavir; best for size, location, and degree of obstruction
Non-emergency/Metabolic Evaluation:
  • 24-hour urine: calcium, oxalate, uric acid, citrate, sodium, creatinine, volume
  • Serum: PTH (if hypercalcemic), uric acid
  • Stone analysis: analyze all passed or retrieved stones
  • Stratify into low-risk (single stone, no metabolic abnormality) vs. high-risk formers

Medical Management

Acute (ureteric colic):
  • NSAIDs (diclofenac, ketorolac) - first-line analgesic; antispasmodics are not necessary
  • Opioids for refractory pain
  • IV hydration if unable to tolerate orally or sepsis is present
Medical Expulsive Therapy (MET):
  • Alpha-1 blockers (tamsulosin): relaxes smooth muscle of the distal ureter; used for distal ureteric stones >5 mm and post-ESWL fragment passage
  • Calcium channel blockers: also reduce dysmotive ureteric contractions while preserving expulsive peristalsis
  • Spontaneous passage rates: ~95-100% for stones <4 mm; ~50% for 5-10 mm; rarely for >10 mm
Prevention - Stone-Specific Pharmacotherapy:
Stone TypeMedicationMechanism
Calcium oxalate (hypercalciuria)HydrochlorothiazideReduces urinary calcium excretion
Calcium oxalate (hypocitraturia)Potassium citrateAlkalinizes urine; increases citrate; chelates calcium
Uric acidPotassium citrate / NaHCO3Alkalinizes urine to pH 6.5-7.0 → uric acid dissolves
Uric acid (hyperuricemic)AllopurinolReduces uric acid production
StruviteAcetohydroxamic acid (urease inhibitor); post-clearance antibioticsInhibits urease; prevents recurrence
CystineHigh fluid intake; D-penicillamine or tiopronin; urine alkalinizationChelation; reduces cystine crystallization
General measures (all patients):
  • Fluid intake >2.5 L/day (target urine output >2 L/day)
  • Do NOT restrict dietary calcium (paradoxically increases oxalate absorption - intestinal calcium binds oxalate in the gut and prevents its absorption)
  • Supplemental calcium should be taken at mealtimes
  • Reduce animal protein and sodium intake
  • Bailey & Love's Surgery 28th ed., p. 1498-1499; Brenner & Rector's The Kidney, p. 1319

3. SURGERY

Indications for Surgical Intervention

  • Failure of medical/conservative management
  • Impaired or deteriorating renal function
  • Complete ureteric obstruction
  • Chronic or recurrent infection (staghorn calculi, matrix calculi)
  • Urosepsis with obstruction (emergency)
  • High-risk occupation (pilots, sailors, long-distance locomotive drivers) or remote geographical location
  • Patient preference

Emergency Urinary Decompression

When urosepsis or complete obstruction is present, decompression takes priority over stone removal:
  • JJ ureteric stent (retrograde; cystoscopy-guided): provides internal drainage
  • Percutaneous nephrostomy (PCN) (antegrade): for failed retrograde approach or anatomical difficulty
  • In selected stable patients without sepsis, ureteroscopy with stone removal can be performed primarily

Extracorporeal Shock Wave Lithotripsy (ESWL)

  • Non-invasive, outpatient procedure; introduced by Christian Chaussy (1980)
  • Mechanism: focused acoustic pulse waves (localized by fluoroscopy ± ultrasound) cause stone fragmentation through direct mechanical stress and cavitation (bubble collapse)
  • Indications: renal and ureteric stones <2 cm; first-line for most renal stones <2 cm with favorable anatomy
  • Absolute contraindications: pregnancy, uncorrected coagulopathy, active UTI, distal obstruction, aortic/renal artery aneurysm
  • Relative contraindications: pacemaker, morbid obesity, musculoskeletal deformities, renal anomalies (horseshoe kidney, pelvic kidney)
  • Complications:
    • Steinstrasse ("street of stones"): row of stone fragments lining the distal ureter; usually pass spontaneously but may obstruct
    • "Clinically insignificant residual fragments" (CIRFs, ≤4 mm): 20-40% fail to clear and form a nidus for recurrence

Ureteroscopy (URS) / Retrograde Intrarenal Surgery (RIRS)

  • Rigid URS: ureteric stones from proximal ureter to UVJ
  • Flexible URS / RIRS: intrarenal stones; access to all calyces
  • Energy sources: holmium:YAG laser (gold standard - works on all stone compositions); pneumatic, electrohydraulic, ultrasonic also used
  • Indications: ureteric stones at any level; renal stones <2 cm; failed ESWL
  • Avoided in children <5 years due to ureteric caliber
  • Day-case procedure; no skin incision required

Percutaneous Nephrolithotomy (PCNL)

  • Removal of renal stones via a dilated percutaneous track (standard >28 Fr) between skin and pelvicalyceal system
  • Position: typically prone; posterolateral calyx used as entry point
  • Guidance: fluoroscopy or ultrasound
  • Energy sources: ultrasound + pneumatic ± laser
Indications:
  • Renal stones >2 cm
  • Lower-pole renal stones with anatomy unfavorable for ESWL
  • Failed ESWL or RIRS
  • Staghorn calculi (first-line; complete clearance mandatory)
Contraindications: pregnancy, untreated UTI, bleeding diathesis, active anticoagulation
Complications:
  • Hemorrhage (can require selective angioembolization)
  • Sepsis/infection
  • Pleural violation (supracostal puncture): pneumothorax, hydrothorax
  • Injury to adjacent organs (bowel, spleen, liver)
Mini-PCNL (<22 Fr): lower bleeding risk; preferred for smaller stone burdens and children
ECIRS (Endoscopic Combined Intrarenal Surgery): simultaneous flexible URS + PCNL; for complex, multiple, or anatomically challenging stones

Open/Laparoscopic Surgery

  • Reserved for complex/infected stones with anatomical abnormalities preventing endourological access
  • Procedures: pyelolithotomy (pelvic stones), anatrophic nephrolithotomy (complex staghorn)
  • Rarely performed in the modern era

Special Situation: Pregnancy

  • Renal colic = the most common cause of non-obstetric hospital admission in pregnancy
  • Physiological changes: increased GFR, progesterone-mediated ureteric dilation, uterine compression
  • Imaging: ultrasound first-line; MRI if needed; CT avoided where possible
  • Treatment: conservative (most stones pass spontaneously); ureteric stent or PCN for obstruction; ESWL contraindicated; URS can be done if necessary
  • Bailey & Love's Surgery 28th ed., p. 1499-1500

Quick Reference Summary

ProcedureStone Size/LocationKey Point
Conservative (MET + analgesia)<10 mm (especially <5 mm)Tamsulosin for distal ureteric stones >5 mm
ESWL<2 cm renal/uretericNon-invasive; fails for cystine; Steinstrasse complication
Ureteroscopy / RIRS<2 cm ureteric/renalHolmium laser; day-case
PCNL>2 cm renal; staghornProne; most invasive; bleeding risk
Ureteric stent / PCNAny size with sepsis or obstructionDecompression first, stone removal later
Open surgeryComplex anatomy; failed endourologyRare in modern practice

Sources used:
  • Robbins & Kumar Basic Pathology, 10th ed., Table 12.5, p. 527-528
  • Robbins, Cotran & Kumar Pathologic Basis of Disease, 10th ed.
  • Bailey & Love's Short Practice of Surgery, 28th ed., Chapter 82, p. 1496-1500
  • Brenner & Rector's The Kidney, 2-Vol Set, Chapter 38, p. 1277-1319
  • Campbell-Walsh-Wein Urology, 12th ed.
This is a shared conversation. Sign in to Orris to start your own chat.